Search results
Results from the WOW.Com Content Network
Gynecologic ultrasonography or gynecologic sonography refers to the application of medical ultrasonography to the female pelvic organs (specifically the uterus, the ovaries, and the fallopian tubes) as well as the bladder, the adnexa, and the recto-uterine pouch. The procedure may lead to other medically relevant findings in the pelvis.This ...
As ovarian cancer is rarely symptomatic until an advanced stage, [42] regular pre-emptive screening is a particularly important tool for avoiding the late stage at which most patients present. However, A 2011 US study found that transvaginal ultrasound and cancer marker CA125 screening did not reduce ovarian cancer mortality. [43]
CT Ovarian Cyst. Further work up involves imaging, such as a pelvic ultrasound or CT scan. [7] Theca lutein cysts with diameters over 6 cm in size can be seen through these imaging modalities. [18] Benign ovarian cysts and complex cysts that are potentially malignant are distinguishable via ultrasounds. [19]
Ovarian squamous cell carcinoma (oSCC) or squamous ovarian carcinoma (SOC) is a rare tumor that accounts for 1% of ovarian cancers. [1] Included in the World Health Organization 's classification of ovarian cancer, [ 2 ] it mainly affects women above 45 years of age.
The most common symptoms of a peritoneal inclusion cyst are persistent abdominal or pelvic pain and a subjectively palpable abdominal mass. [2] Often, a physical examination reveals no palpable mass in the abdomen or pelvis. [3] The symptoms can last for days or months at a time. [4]
[10] Oncology. Ultrasound can ablate tumors or other tissue non-invasively. [4] This is accomplished using a technique known as high intensity focused ultrasound (HIFU), also called focused ultrasound surgery. This procedure uses generally lower frequencies than medical diagnostic ultrasound (250–2000 kHz), but significantly higher time ...
OGCT is a rare tumour under the scope of ovarian cancer, accounting for less than 5% of all ovarian malignancies. It occurs mostly in 15-19-year-old women and shows 75% incidence rate for women aged <30 years. [31] In 2011, the number of new cases occurred worldwide is 5.3 per million. [32]
Cystadenocarcinoma is a malignant form of a cystadenoma and is a cancer derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur.